medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2023, Number 3

<< Back Next >>

Acta Med 2023; 21 (3)

Thromboprophylaxis in a private hospital

García MLE, Fernández RE, Saucedo MEM, Chimal JMF, Gaona RF

Language: Spanish
References: 16
Page: 247-252
PDF size: 188.15 Kb.


ABSTRACT

Introduction: venous thrombosis is an entity considered the main cause of preventable death in the hospital environment, the use of thromboprophylaxis is usually very varied with regular adherence to the recommendations described in the international literature. Objective: to evaluate the VTE risk profile of recently admitted clinical and surgical patients and the thromboprophylactic measures applied in the first 24 hours of hospitalization. Material and methods: this cross-sectional study was conducted in a private hospital. The Caprini and Padua score was used to stratify the risk of clinical and surgical patients. The analysis of thromboprophylactic measures was based on the recommendations of the 9th consensus of the American College of Chest Physicians. Results: 592 patients were analyzed. Risk stratification revealed the need for thromboprophylaxis in 42% of clinical patients and 81% of surgical patients (51% high risk and 30% moderate risk). On the other hand, 54% of high-risk clinical patients received adequate prophylaxis in the first 24 hours of hospitalization. Conclusions: there is a need to improve patient safety concerning VTE in the first hours of hospitalization. There is a sub-utilization of thromboprophylaxis, especially in high-risk clinical and moderate-risk surgical patients.


REFERENCES

  1. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med [Internet]. 1991; 151 (5): 933-938. Available in: https://pubmed.ncbi.nlm.nih.gov/2025141/

  2. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation [Internet]. 2003; 107 (23 Suppl 1): 9-16. Available in: https://pubmed.ncbi.nlm.nih.gov/12814980/

  3. Awidi A, Obeidat N, Magablah A, Bsoul N. Risk stratification for venous thromboembolism in hospitalized patients in a developing country: a prospective study. J Thromb Thrombolysis [Internet]. 2009; 28 (3): 309-313. Available in: https://pubmed.ncbi.nlm.nih.gov/19023522/

  4. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg [Internet]. 2010; 251 (2): 344-350. Available in: https://pubmed.ncbi.nlm.nih.gov/19779324/

  5. Kniffin WJ, Baron J, Barrett J, Birkmeyer J, Anderson F Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med [Internet]. 1994; 154 (8): 861-866. Available in: https://europepmc.org/article/MED/8154949

  6. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med [Internet]. 2003; 349 (13): 1227-1235. Available in: https://www.nejm.org/doi/full/10.1056/NEJMoa023153

  7. Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost [Internet]. 2007; 5 Suppl 1: 41-50. Available in: https://pubmed.ncbi.nlm.nih.gov/17635707/

  8. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008; 371 (9610): 387-394.

  9. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest [Internet]. 2008; 133 (6 Suppl): 381S-453S. Available in: https://pubmed.ncbi.nlm.nih.gov/18574271/

  10. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest [Internet]. 2012; 141 (2 Suppl): e195S-e226S. Available in: https://pubmed.ncbi.nlm.nih.gov/22315261/

  11. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost [Internet]. 2010; 8 (11): 2450-2457. Available in: https://pubmed.ncbi.nlm.nih.gov/20738765/

  12. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005; 51 (2-3): 70-78.

  13. Dhamnaskar S, Trivedi UJ, Sawarkar P, Kulkarni V. Prospective observational study of compliance to venous-thromboembolism prophylaxis guidelines as per the American College of Chest Physicians (ACCP) in post-operative patients in a Tertiary Care Centre. Int J Health Sci Res. 2016; 6 (5): 39-46.

  14. Machado NLB, Leite TL, Pitta GBB. Frequency of mechanical prophylaxis for deep venous thrombosis in patients admitted to an emergency room in Maceió, Brazil. J Vasc Bras. 2008; 7 (4): 333-340.

  15. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest [Internet]. 2012; 141 (2 Suppl): e152S-e184S. Available in: https://pubmed.ncbi.nlm.nih.gov/22315259/

  16. Wells P, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet [Internet]. 1997; 350 (9094): 1795-1798. Available in: https://pubmed.ncbi.nlm.nih.gov/9428249/




2020     |     www.medigraphic.com